The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19: Do the CFREU Provisions Retain Any Relevance?

Nasiya Daminova

The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19: Do the CFREU Provisions Retain Any Relevance?

Nasiya Daminova

Tutkimustuotos: Työpaperi

51 Lataukset (Pure)

Alkuperäiskieli	Englanti
Kustantaja	Társadalomtudományi Kutatóközpont
Sivumäärä	30
Tila	Julkaistu - 2021
Julkaistu ulkoisesti	Kyllä
OKM-julkaisutyyppi	D4 Julkaistu kehittämis- tai tutkimusraportti taikka -selvitys

Julkaisusarja

Nimi	MTA Law Working Papers
Numero	2021/1
ISSN (elektroninen)	2064-4515

Pääsy asiakirjaan

The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Final published version, 1,34 MBLisenssi: Unspecified

Siteeraa tätä

Daminova, N. (2021). The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19: Do the CFREU Provisions Retain Any Relevance? (MTA Law Working Papers; Nro 2021/1). Társadalomtudományi Kutatóközpont. https://jog.tk.mta.hu/mtalwp/the-european-medicines-agency-transparency-policies-the-cjeu-and-covid-19-do-the-cfreu-provisions-retain-any-relevance

@techreport{18dd942fe3db47f291cc037a4735b4d9,

title = "The European Medicines Agency {\textquoteleft}Transparency{\textquoteright} Policies, the CJEU and COVID-19: Do the CFREU Provisions Retain Any Relevance?",

author = "Nasiya Daminova",

year = "2021",

language = "English",

series = "MTA Law Working Papers",

publisher = "T{\'a}rsadalomtudom{\'a}nyi Kutat{\'o}k{\"o}zpont",

number = "2021/1",

type = "WorkingPaper",

institution = "T{\'a}rsadalomtudom{\'a}nyi Kutat{\'o}k{\"o}zpont",

}

Daminova, N 2021 'The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19: Do the CFREU Provisions Retain Any Relevance?' MTA Law Working Papers, Nro 2021/1, Társadalomtudományi Kutatóközpont. <https://jog.tk.mta.hu/mtalwp/the-european-medicines-agency-transparency-policies-the-cjeu-and-covid-19-do-the-cfreu-provisions-retain-any-relevance>

TY - UNPB

T1 - The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19

T2 - Do the CFREU Provisions Retain Any Relevance?

AU - Daminova, Nasiya

PY - 2021

Y1 - 2021

M3 - Working paper

T3 - MTA Law Working Papers

BT - The European Medicines Agency ‘Transparency’ Policies, the CJEU and COVID-19

PB - Társadalomtudományi Kutatóközpont

ER -